dm+d
703906002
Articles
Understanding direct oral anticoagulant (DOAC) interactions
5 January 2024
Using intramuscular injections in people on oral anticoagulants
20 September 2023
Accessing resources for patients on high risk medicines
19 December 2022A number of resources are available to support the safe use of high-risk medicines. Healthcare professionals should ensure they are available for their patients
Using oral anticoagulants during breastfeeding
2 November 2021Thromboembolic disease management whilst breastfeeding is challenging. Warfarin is the preferred choice. Guidance on using DOACs is also provided.
Medicine Compliance Aid Stability
EliquisBristol-Myers Squibb-Pfizer
Bristol-Myers Squibb-Pfizer
Eliquis
Tablets f/c 2.5mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special precautions for storage.
25 October 2022
Lactation Safety Information
Warfarin, Rivaroxaban, Dabigatran
Direct activated factor X inhibitor
Limited published evidence which shows relatively high milk levels
Effect on the breastfed infant remains unknown
2 November 2021